Catalyst Wire Dossier Catalyst Wire Dossier

GSK1322322

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for GSK1322322, covering 2015-01-28 to 2017-12-04. Get the full timeline:

Most recent: Clinical Trial Update: GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection [Phase 2]

See pricing